|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-3-13
|
|
pubmed:abstractText |
HDL is a recognized negative risk factor for the cardiovascular diseases. Establishing the genetic determinants of HDL concentration and functions would add to the prediction of cardiovascular risk and point to the biochemical mechanisms underlying this risk. The present review focuses on various approaches to establish genetic determinants of the HDL concentration, structure and function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0957-9672
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
157-63
|
|
pubmed:meshHeading |
pubmed-meshheading:17353664-ATP-Binding Cassette Transporters,
pubmed-meshheading:17353664-Apolipoprotein A-I,
pubmed-meshheading:17353664-Apolipoproteins E,
pubmed-meshheading:17353664-Cardiovascular Diseases,
pubmed-meshheading:17353664-Cholesterol Ester Transfer Proteins,
pubmed-meshheading:17353664-Ethnic Groups,
pubmed-meshheading:17353664-Exons,
pubmed-meshheading:17353664-Humans,
pubmed-meshheading:17353664-Lipoproteins, HDL,
pubmed-meshheading:17353664-Phosphatidylcholine-Sterol O-Acyltransferase,
pubmed-meshheading:17353664-Risk Factors
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Genetic factors affecting HDL levels, structure, metabolism and function.
|
|
pubmed:affiliation |
Baker Heart Research Institute, Melbourne, Victoria, Australia. Dmitr.Sviridov@Baker.edu.au
|
|
pubmed:publicationType |
Journal Article,
Review
|
